Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Williams

Showing results (281-290 of 293) with videos related to

Pageof 30
Sort By:
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Journal of Extracellular Vesicles|February 7, 2024
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJoshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global ConsortiumGabriel A de Erausquin, Heather Snyder, Traolach S Brugha, et al.
Pageof 30

Showing results (281-290 of 293) with videos related to

Sort By:
Pageof 30
Nature Communications|August 7, 2021
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronavirusesNatalia Ortega, Marta Ribes, Marta Vidal, et al.
Genes and Immunity|April 22, 2025
A scan of pleiotropic immune mediated disease genes identifies novel determinants of baseline FVIII inhibitor status in hemophilia AMarcio A Almeida, Vincent P Diego, Kevin R Viel, et al.
The Lancet. Oncology|May 26, 2022
Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control studyLennard Y W Lee, Thomas Starkey, Maria C Ionescu, et al.
Nature|July 1, 2016
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P Chen, Matthew J LaMarche, Ho Man Chan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 9, 2022
COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based studyLennard Y W Lee, Maria C Ionescu, Thomas Starkey, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Scientific Reports|July 25, 2023
A population-scale temporal case-control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP)Thomas Starkey, Maria C Ionescu, Michael Tilby, et al.
Neurology|March 6, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral BackgroundsBenjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels, et al.
Journal of Extracellular Vesicles|February 7, 2024
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJoshua A Welsh, Deborah C I Goberdhan, Lorraine O'Driscoll, et al.
Alzheimer'S & Dementia (New York, N. Y.)|October 3, 2022
Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global ConsortiumGabriel A de Erausquin, Heather Snyder, Traolach S Brugha, et al.
Pageof 30